Medicus Pharma Ltd (MDCX) Annual Income Statement

Annual · GAAP · USD millions
Access MDCX quarterly income statements →
Quarterly income statement trends provide context on Medicus Pharma Ltd's margins, operating leverage, and earnings trajectory.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MDCX/income-statements
https://api.csimarket.com/api/v1/companies/MDCX/fundamentals
https://api.csimarket.com/api/v1/companies/MDCX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing17.92
Research and Development Expense8.72
Other Operating Expense / -Income7.72
Total operating costs including COS34.36
Operating income / -loss-34.36
Interest Expense0.20
Net Interest (-)Expense / Income0.20
Extinguishment of Debt-0.03
Investment Income, Net0.00
Foreign Currency Transaction Gain (Loss), before Tax-0.01
Other loss / -income0.92
Total costs & expenses35.44
Income & Taxes
Income / -loss before income taxes-35.44
Income after income taxes-35.44
Income / -loss from continuing operations-35.44
Non-controlling interests0.00
Net income / -loss-35.44
Income / -loss to shareholder-47.28
EBIT-35.64
EBITD-35.64
EBITDA-35.64
Earnings Per Share
Basic EPS (excl. extra items)-2.74
Basic Net EPS-2.74
Basic shares outstanding (Mill. of Units)17.28
Diluted Net EPS-2.74
Diluted average shares (Mill. of Units)17.28
4 historic quarters locked

Sign in to unlock the full Medicus Pharma Ltd income statement history.

About Medicus Pharma Ltd Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 25, 2026
  • Original filing: form10k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI